nivolumab,ipilimumab
bms
[]
tech is v cool, but #biotech is unarguably cooler! here s data results for the history books #esmo2022 
Investor Relations @ultimovacs (OSE: ULTI) developing novel immunotherapy cancer treatment. Angel investor in tech, impact & sustainability ??, VP @antlerglobal